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ABSTRACT
THE ROLE OF CYTOPROTECTIVE AND NON-PROTECTIVE AUTOPHAGY IN
RADIATION SENSITIVITY IN BREAST TUMOR CELLS
Le, J; Nakajima, W; Harada, H; and Gewirtz, D.

A thesis in partial fulfillment of the requirements for the degree of
Master of Science in Pharmacology and Toxicology at
Virginia Commonwealth University, 2014

By Jade Ngoc Le

Major Director: David Gewirtz
Professor, Department of Pharmacology and Toxicology
Richmond, Virginia

In general, ionizing radiation promotes cytoprotective autophagy in a majority of
breast tumor cells. Previous studies from our laboratory indicated that radiation (5x2
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Gy) induces cytoprotective autophagy in MCF-7 cells. In the current work, inhibition of
autophagy by silencing of Beclin-1 in MCF-7 cells resulted in an increase in sensitivity
to radiation based both on cell number and clonogenic survival; however, there was
no increase in apoptosis and the basis for this sensitization is currently under
investigation. Unexpectedly, enhancement of autophagy by silencing of Bcl-2 also led
to an increase in sensitivity to radiation, possibly through the conversion of
cytoprotective to cytostatic autophagy. In contrast to the MCF-7 cells, radiation (5x2
Gy) induces non-protective autophagy in Hs578t cells. Interference with autophagy
through silencing of Beclin-1 or induction of Bcl-2 did not alter radiation sensitivity in
the Hs578t cells. Since the induction of cytoprotective autophagy can represent an
impediment to radiation therapy, it is important to understand the types of autophagy
that occur in response to radiation in specific cellular settings and whether
interference with autophagy can increase sensitivity to different forms of cancer
treatment.
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CHAPTER 1: INTRODUCTION
1.1 Cancer
Cancer is a major public health problem in the United States and other countries
around the world. According to Siegel et al. (Siegel et al., 2013), one in four
deaths in the United States are due to cancer. Cancer can be understood as a
disease of malfunctioning cells that keep growing and accumulating. It is the
general name for a group of more than 100 diseases, and can be grouped into
five categories:
Carcinoma: cancer that arises from epithelial tissues that line the walls of
cavities or in the case of skin covering the outside of the body and is responsible
for more than 80% of the cancer-related death in the Western world. There are
two main types of carcinoma that include squamous cell carcinomas—tumors
that arise from epithelial cells that line and protect the underlying cells, and
adenocarcinomas—tumors that arise from specialized epithelial cells that
secrete substances into the ducts or cavities that they line (Weinberg, R., 2007).
Sarcoma: cancer that begins in bone, cartilage, fat, muscles, blood vessels, or
other connective or supportive tissues (www.cancer.gov). The sarcomas
constitute about 1% of the tumors encountered in the oncology clinic (Weinberg,
R., 2007).
Leukemia: cancer arises from cell lineages that constitute the blood-forming
tissues and move freely through the circulation.
Lymphomas: cancer begins in the cells of the immune system that aggregate to
form solid tumors.
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Central nervous system cancer: cancers arise from cells that form the central
and peripheral nervous system.
1.2 Breast Cancer
Breast cancer is the second leading cause of cancer death in women in the
United States (Jemal et al., 2011). According to the U.S. Breast Cancer
Statistics 2013, about one in eight women in the U.S. will develop invasive
breast cancer over the course of her life (www.breastcancer.org). Breast cancer
can be divided into 2 large groups based on specific molecular markers
including hormone-receptor [HR; estrogen receptor (ER) and progesterone
receptor (PR)]-positive and HR-negative negative breast cancers. The HRpositive breast cancer can be sub-divided into two groups defined as luminal A
and B tumors depending on the expression level of human epidermal growth
factor receptor 2 (HER2). The HR-negative breast cancer can be sub-divided
into

two

groups

determined

by

HER2

expression

including

HER2-

overexpressing tumors and HER2-negative tumors (Rakha et al., 2008).
About 65-70% of invasive breast cancers are HR-positive tumors, called luminal
tumors, whose cells express high level of estrogen-hormone receptors and/or
progesterone-hormone receptors and associated genes (Schnitt, 2010). The
luminal type of breast cancer tends to exhibit a good prognosis since they are
estrogen receptor-positive (ER+) and/or progesterone receptor-positive (PR+).
The luminal A subtype is characterized by lacking the human epidermal growth
factor receptor 2 (HER2-) which distinguishes it from the luminal B subtype. The
first line clinical treatment of luminal type of breast cancer is endocrine therapy,
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through targeting of hormone functions (tamoxifen to inhibit ER function) or
blocking their synthesis (aromatase inhibitor to block estrogen synthesis).
Usually, luminal A subtype exhibits better clinical outcomes in response to
endocrine therapy than luminal B subtypes. Since 30% of ER+ breast cancers
were reported resistant to hormonal therapy, additional therapeutic strategies
are required for optimal outcomes (Zhang et al., 2014).
About

15%

of

invasive

breast

cancers

are

characterized

by

HER2

overexpression. HER2 overexpression in breast tumors is often associated with
low expression of ER and associated genes (Schnitt, 2010). HER2- human
epidermal growth factor 2- belongs to a family of receptors including
EGFR/HER1, HER2, HER3, and HER4 and functions by stimulating the
signaling pathway of growth factors (Gajria and Chandarlapaty, 2011). Overexpression of HER2 leads to the continued activation of growth signaling
pathway and contributes to the growth of breast cancer cells. HER2-positive
breast cancer tends to be aggressive, fast growing, and less responsive to
hormonal therapy. However, treatments for HER2-positive breast cancer have
been shown to be very effective when pharmacologically targeting at HER2. The
most common pharmacologic treatment used is trastuzumab (Herceptin), a
monoclonal antibody that binds to the extracellular domain of HER2 receptors,
blocking cancer cells but not normal cells from receiving growth signals. The use
of trastuzumab in combination with chemotherapy shows effectiveness in the
case of advanced-stage breast cancer and reduces the risk of disease
recurrence (Gajria and Chandarlapaty, 2011).
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Another group belonging to the HR-negative subtype is triple negative (TN)
breast cancer, which constitutes about 12-24% of breast cancer (Sorlie et al.,
2001; Bertucci et al., 2000; Bertucci et al., 2004). TN breast cancer is defined as
HR negative/PR negative/HER2 negative, and does not benefit from some of the
most effective therapies against breast cancer such as hormonal therapy or
HER2 targeting therapy (Rakha et al., 2008). TN breast cancer is associated with
a worse prognosis, has a high rate of recurrence, and causes majority of death
within the first 3 to 5 years after initial treatment (Ovcaricek et al., 2011).
Chemotherapy is usually the only therapeutic option to treat TN breast cancer
because of their lack of hormonal receptors and HER2. Anthracycline and
anthracycline/taxane treatment usually results in good initial effects in treating of
TN breast tumors, but they also yield a rapid relapse rate. Currently, there are
several emerging agents under clinical trials for treatment of TN breast cancer
such as platinum agent, poly (ADP-ribose) polymerase (PARP) inhibitors which
interfere with DNA repair and are hoped to improve prognosis for patients with
TN breast cancer (Ovcaricek et al., 2011).
1.3. Autophagy
Autophagy is a self-eating process by which cytoplasmic materials are delivered
to and degraded in the lysosome (Mizushima and Komatsu, 2011). There are
three major types of autophagy depending on the route by which the cytoplasmic
materials delivered to the lysosome: chaperone-mediated autophagy (CMA),
microautophagy, and macroautophagy (Klionsky, 2005). In CMA, unfolded,
soluble proteins are directly translocated across the lysosomal membrane
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without involvement of membrane formation. In microautophagy, cytoplasmic
materials are directly engulfed into the lysosome by inward invagination of the
lysosomal membrane (Mizushima and Komatsu, 2011). Macroautophagy
(hereafter referred to as autophagy), which is thought to be the major type of
autophagy, involves the intermediate formation of autophagosomes, which
sequester cytoplasmic materials, and finally fuse with the lysosome to degrade
the components.
Autophagy is a dynamic and multi-step process. The Atg1/ULK1 complex is an
essential initiator of autophagy, which is normally remained inactivated by
binding with mammalian Target of rapamycin (mTORC1), a master regulator of
nutrient signaling. Under stressful conditions such as nutrition starvation,
mTORC1 dissociates from the Atg1/ULK1 complex, and allows the complex to
phosphorylate

downstream

Atg

proteins

for

autophagosome

formation

(Mizushima, 2010). The autophagosome is a double-membrane organelle that is
derived from endoplasmic reticulum, Golgi apparatus, and/or mitochondria
organelles. The autophagosome formation process consists of four major steps
including isolation membrane formation, nucleation, elongation, and completion
steps. Initially, the class III phosphoinositide 3-kinase (PI3K or Vps34) is
associated with Beclin-1 (Atg6) and p150 to form the class III PI3K core complex.
The complex triggers vesicle nucleation, which sequesters the cytoplasmic
component into an isolation membrane called the phagophore. Next, complete
sequestration and phagophore elongation are supported by two ubiquitin-like
protein conjugation systems Atg12-Atg5 complex and LC3 (Atg8). The Atg12-
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Atg5 complex consists of Atg12, Atg5, and Atg16L and plays role in recruiting
additional membrane to complete the autophagosomes membrane formation.
Then, lipidated LC3-II (a PE conjugated form of LC3 after the protein is cleaved
by Atg4) associates with the newly formed autophagosomes to become the inner
composition of autophagosomal membrane. Next, autophagosomes fuses with
lysosomes, forming the autophagolysosome, to complete the autophagy
pathway. This degradative process of autophagy is selective and mediated
through p62/sequestosome 1 (SQSTM1), a mammalian protein that binds to LC3
(Bjorkoy et al., 2005; He and Klionsky, 2009). Finally, the inner membrane of the
autophagosomes and the ubiquinated cargo are degraded by lysosomal
hydrolase to complete the autophagic degradation (Pyo et al., 2012).
Autophagy is an important catabolic mechanism that occurs in cancer (Ouyang et
al., 2012). The functions of autophagy in tumor cells are controversial and
remained to be elucidated. In general, autophagy is well known for its
cytoprotective function to maintain the cell homeostasis during period of
starvation or stresses (He and Klionsky, 2009; Ouyyang et al., 2012). It is also
well established that autophagy can induce cell death independently of other
types of programmed cell deaths such as apoptosis when coping with excessive
stress (Bialik et al., 2010; Eisenberg-Lerner et al., 2009; Ouyang et al., 2012).
Recently, it has been proposed that at least two more functions of autophagy
may occur in response to stresses, including non-protective and cytostatic
functions (Gewirtz, 2014). Thus, it is challenging but critical to analyze which
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function autophagy plays in cancer cells in response to stressful conditions such
as radiation and chemotherapy treatments.

Figure 1.1. Various steps involved in autophagy (Denton et al., 2012).
1.4 Apoptosis
Apoptosis, or type I programmed cell death (PCD), is a major cell death modality
to control cell proliferation or in response to DNA damage (Ghobrial et al., 2005).
Apoptosis is characterized by nuclear condensation and fragmentation, cell
shrinkage, dynamic membrane blebbing, and loss of adhesion to the
surroundings (Nishida et al., 2008; Ouyang et al., 2012) Apoptosis can occur
through two main pathways: the extrinsic or cytoplasmic pathway, and the
intrinsic or mitochondrial pathway. The two pathways will finally converge to the
activation of a cascade of caspase proteases for execution of the apoptosis
process (Ghobrial et al., 2005).
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The extrinsic apoptotic pathway is triggered when extracellular ligand Fas-L
binds to Fas plasma membrane death receptor (or other similar receptors). The
Fas complex then recruits Fas-associated death domain protein (FADD) and procaspase-8 to activate caspase-8, which in turn proceeds to activate the rest of
the downstream caspases (Wajant, 2002).
The intrinsic apoptotic pathway is involved in the activation and translocation of
proapoptotic proteins to the mitochondria. The BCL-2 (B cell lymphoma gene-2)
family proteins are key regulators of the intrinsic apoptotic pathway and can be
classified into pro-apoptotic and anti-apoptotic functions (Weinberg, 2007). The
pro-apoptotic proteins are divided into two groups: the BH-3 only proteins (Bad,
Bid, Bim, Bmf, Bik, Hrk, Noxa, and Puma) and the multidomain proteins (Bax,
Bak, and Bok). The anti-apoptotic proteins include Bcl-2, Bcl-xL, Bcl-w, and Mcl1 which antagonize Bax/Bak under normal conditions. In response to intrinsic
apoptotic stimuli, the BH-3 only proteins are activated and subsequently block
the Bcl-2 proteins anti-apoptotic function. Thus, Bax/Bak are activated and
mediated the release cytochrome c from the mitochondria into the cytosol.
Cytochrome c then recruits Apaf-1 and pro-caspase-9, leading to the activation of
caspase-9, which in turn activates the rest of the downstream signaling cascade
and leads to apoptosis (Ghobrial et al., 2005).

9"
"

Figure 1.2. Schematic extrinsic and intrinsic pathways of apoptosis (Youle and
Strasser, 2008).
1.5 Bcl-2:Beclin-1 interaction regulates autophagy
Beclin-1 is a key regulator of autophagy in mammalian cells (Liang et al., 1999;
Cao and Klionsky, 2007). Beclin-1 recruits key autophagic proteins to promote
formation of a complex of Beclin 1, Vps34, and Vps15 which is important to
initiate the autophagosome formation and induce autophagy (He and Levine,
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2010). Recently, Beclin-1 was classified as a BH-3 only protein, which binds to
the anti-apoptotic Bcl-2 proteins (Oberstein et al., 2007). The Beclin-1/Bcl-2
interaction functions as a key regulatory mechanism in Beclin-1-dependent
autophagy (Decuypere et al., 2012). In normal conditions, Bcl-2 binds to Beclin-1
and inhibits its autophagy function. When the cells are under stressful conditions,
Beclin-1 dissociates from Bcl-2 and associates with Vps34, allowing subsequent
activation of autophagy (Decuypere et al., 2012). It is also important to mention
that not mitochondrial but only ER-localized Bcl-2 is able to regulate Beclin-1dependent autophagy (Pattingre et al., 2005).

Figure 1.3. Bcl-2 as an anti-apoptosis and anti-autophagy protein (Marquez and
Xu, 2012).
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1.6 Previous studies
Previously our lab has demonstrated that MCF-7 breast cancer cells when
irradiated with fractionated doses of 5x2 Gy induced cytoprotective autophagy
which prevented radiation-induced cell death. However, when radiation was used
in combination with EB1089, an analog of Vitamin D, cytoprotective autophagy
was converted into cytotoxic form, which was associated with a reduction in the
number of viable cells (Wilson et al., 2011; Bristol et al., 2012). Thereby,
cytotoxic and cytoprotective functions of autophagy can occur in the same
experimental system, which can be exploited to enhance the effects of cancer
therapies. In addition, data from our lab (Chakradeo et al., manuscript in
preparation) have demonstrated that fractionated doses of 5x2 Gy did not induce
cytoprotective autophagy in Hs578t breast cancer cells. Instead, the autophagy
induced in Hs578t when being blocked with autophagy inhibitors 3methyladenine (3-MA) and Chloroquine (CQ) did not sensitize the cells to
radiation treatment. Thereby, our lab has termed it non-protective autophagy.
Furthermore, recent studies from our lab also demonstrated that another function
of autophagy, termed cytostatic autophagy, could be induced and resulted in
cellular growth arrest. Thus, we suggested that multiple functions of autophagy
can occur between different cells lines and/or conversion can happen within one
cellular system. Since autophagy can be a mode of cellular resistance to
treatment, interference of autophagy, therefore, can increase sensitivity to
treatment and can become therapeutic benefits to cancer therapy.
1.7 Hypothesis
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Numerous studies have suggested that autophagy can function as either
cytoprotective (pro-survival) or cytotoxic (pro-death) functions (Levine and Yuan,
2005; Eskelinen, 2005; Zong and Thompson, 2006; Nelson and White, 2004). In
addition, studies from our lab have indicated that using the same radiation
treatment condition (5 x 2Gy) resulted in the induction of cytoprotective
autophagy in MCF-7 cells (Wilson et al., 2011; Bristol et al., 2012) and nonprotective autophagy in Hs578t (manuscript in preparation). Here, I hypothesize
that enhancement of radiation-induced autophagy in MCF-7 cells leads to a
decrease in sensitivity to radiation. In contrast, interference in radiation-induced
autophagy in Hs578t does not alter sensitivity to radiation.
CHAPTER 2: MATERIALS AND METHODS
2.1 Cell lines and cell culture.
MCF-7 and Hs578t mammalian breast tumor cell lines were purchased from the
American Type Culture Collection (ATCC). 293T cells were kindly provided by
Dr. Hisashi Harada (Virginia Commonwealth University, VA, USA). MCF-7/shBcl2, MCF-7/shBeclin-1, Hs578t/Bcl-2, and Hs578t/shBeclin-1 cells were maintained
using (1ug/ml) puromycin (Sigma p8833) for selection. All the cells were cultured
in DMEM supplemented with 10% heat-activated fetal bovine serum (FBS) and
5% of 100ug/ml penicillin G/streptomycin and maintained at 37oC in a humidified,
5% CO2 incubator.
2.2 Plasmid construction and virus infection.
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The lentiviral shRNA constructs to target Bcl-2 and Beclin-1 were kindly provided
by Dr. Hisashi Harada (Virginia Commonwealth University, VA, USA). To
generate recombinant lentivirus, the 293T cells (1 x 106 cells total) were plated on
a 10mm cell culture dish. Transfection steps were carried out 2 days later as the
293T became approximately 70% confluence. First, 5µg of the shRNA constructs
(including 2.5µg of interested shRNA and 2.5µg of lentiviral packaging plamids)
were mixed into 200µL of RPMI medium (Gibco). In a separate tube, 15µL of
Lipofectamine 2000 reagent (Invitrogen) was diluted into another 200µL of RPMI
medium. Next, the diluted Lipofectamine reagent was added drop wise into the
DNA solution while gently vortexing the DNA-containing tube. The mixture was
incubated for 15-20 minutes at room temperature. Finally, the DNALipofectamine mixture was added gently into the 293T cells. The medium was
replaced after 14-18 hours overnight. After two days of incubation, the lentivirus
shed into the medium was collected and used to infect the breast tumor cells of
interest.
The retrovirus pBabe-puro Bcl-2 expressing vector was kindly provided by Dr.
Wataru Nakajima (Nippon Medical School, Kawasaki, Japan). The vector was
transfected into 293T cells along with the retrovirus packaging plasmids. The
retrovirus shed into the medium was collected and used to infect Hs578t cells.
2.3 Cell viability and clonogenic survival.
Cell viability was determined by Trypan blue exclusion assay at different time
points after treatment. The cells were seeded in triplicate in twelve well tissue
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culture dishes with a concentration of 0.5 x 105 cells per well in 1ml medium. The
cells were trypsinized and collected together with the supernatant, centrifuged at
4000 x g for 5 minutes, and washed twice with PBS. The viability was determined
using 0.4% Trypan Blue dye (Sigma T8154), and counted using phase contrast
microscopy. For clonogenic survival studies, treated cells were plated in six well
tissue culture dishes with a concentration of 1 x 104 cells per well in 2ml medium.
After 12 days, the cells were fixed with 100% methanol, air-dried, and stained
with 0.1% crystal violet (Sigma C3886). Number of counted colonies was
normalized relative to untreated controls, which were taken as 100% survival.
2.4 Detection and quantification of autophagic cells.
Acridine orange allows the visualization of an autophagy marker, which is the
cellular acidic compartment. Cells were plated in triplicate in six well tissue
culture dishes and treated as described above for the cell viability study. After
treatment fort appropriate times, the cells were incubated with medium containing
1µg/ml acridine orange (Invitrogen A3568) for 10 minutes. The medium
containing acridine orange was removed, and the cells were washed once with
PBS. Fresh PBS was added, and images were taken using an Olympus inverted
fluorescence microscope. All images were taken under 20x magnifications. Flow
cytometry was used to quantify for the number of cells with acidic vesicular
organelles (AVO). The cells were treated in the same manner and analyzed by
BD FACSCanto II using FCS Express 4 Flow Research Edition software. A
minimum of 10000 cells within the gated region was analyzed.
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2.5 Immunoprecipitation and Western blot analyses.
For immunoprecipitation, cells were lysed in CHAPS lysis buffer (20mM Tris (pH
7.4), 137 mM NaCl, 1 mM dithiothreitol (DTT), and 1% CHAPS (3-[(3cholamidopropyl)

dimethylammonio]-1-propanesulfonate)

containing

1:50

protease inhibitor and 1:100 phosphatase inhibitors in M-PER mammalian
protein extraction reagent (Thermo Scientific). 500 µg of protein were captured
with protein G Sepharose beads (Pharmacia LKB, Biotechnology AB, Uppsala,
Sweden) and incubated with Beclin-1 antibody (Cell Signaling) at 4oC for 2 hours.
After 3 times washing with the same CHAPS lysis buffer, the beads were resuspended in sample buffer and separated by SDS-PAGE. For Western blotting
analyses, cells were lysed with lysis buffer containing 1:50 protease inhibitor and
1:100 phosphatase inhibitor in M-PER mammalian protein extraction reagent
(Thermo Scientific). Equal amounts of proteins were loaded on a SDS acrylamide
gel, transferred onto a PVDF membrane using transfer buffer (700ml DI water,
200ml methanol, and 100ml 10X Tris/Glycine). The membrane was blocked for
30 minutes using blotto mixture (5% skim milk in 0.1% Tween-20 of 1 x PBS).
After blocking, the membrane was incubated with respective antibodies
overnight. After three times washing with TPBS (0.1% Tween-20 of 1 x PBS), the
membrane was incubated with appropriate secondary antibodies followed by
three times washing with TPBS. The membrane was developed using Pierce
ECL Plus Western Blotting Substrate (Thermo Sciencetific #32132). Protein
concentrations were determined using Bradford method. Primary antibodies used
were cleaved PARP (Cell Signaling), p62 (BD Transduction), Beclin-1(Cell
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Signaling), Mcl-1 (Enzo), Bcl-xL (Cell Signaling), Bcl-2 (Sigma), LC3 (Cell
Signaling). All primary antibodies presented were used at a 1:1000 dilution.
2.6 Statistical analysis.
Values represent the means +/- SE for three separate experiments. The
significance of differences between the experimental variables was analyzed
using a one-way ANOVA followed by Bonferroni post-hoc test. Values with
P<0.05 were considered as statistically different.
CHAPTER 3: RESULTS
Section 1: Radiation induced cytoprotective autophagy in MCF-7 cell.
3.1.1 Silencing of Beclin-1 inhibited autophagy and increased sensitivity in
MCF-7 cell in response to radiation.
In MCF-7, ionizing radiation at 5x2 Gy promoted cytoprotective autophagy.
Pharmacological inhibition of autophagy using 3-methyladenine (10mM) and
chloroquine (25µM) resulted in growth inhibition or cell death (Wilson et al., 2011;
Bristol et al., 2012). To further confirm previous results, I generated a stable
MCF-7 cell line that expressed Beclin-1 short-hairpin RNA (shRNA). Figure
3.1.1a shows that Beclin-1 expression was successfully suppressed in MCF-7
cell. Acridine orange staining was utilized to monitor the induction of autophagy
(which stains the late state of autophagosomes after fusion with lysosomes,
indicated as acidic vesicular organelles). Figure 3.1.1b indicates that radiation
alone induced autophagic vesicle formation in MCF-7/control cell. Silencing of
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Beclin-1 reduced the increased level of autophagic vesicles caused by radiation.
In Figure 3.1.1c, quantification of acidic vesicular organelles indicates that
radiation-induced autophagy was statistically significant within 0 hour post
radiation. Silencing of Beclin-1 could suppress or at least did not promote the
formation of acidic vesicular organelles. To further assess whether silencing of
Beclin-1 could inhibit the completion of autophagy, or autophagic flux, I
performed Western blot analysis to examine the degradation of p62 protein. The
protein p62, also mentioned as sequestosome 1 (SQSTM1), is an LC3-II binding
protein whose degradation is indicative of autophagic flux. In Figure 3.1.1d, down
regulation of p62 was observed at 24 hours post radiation in MCF-7. On the other
hand, p62 level remained unchanged at 0 hour and 24 hours post radiation in
MCF-7/shBeclin-1 as compared to the NT (none treatment) cells. Thus silencing
of Beclin-1 could inhibit autophagy induced by radiation in MCF-7 cells.
Next, Trypan blue exclusion assay was performed to determine the number of
viable cells after Beclin-1 silencing. In Figure 3.1.1e, radiation alone could induce
about 50% of growth inhibition at 0 hour post radiation and 60% at 24 hours in
MCF-7/control cell. When radiation was performed in combination with Beclin-1
silencing, the growth inhibition effects were increased to 80% at 0 hour and 70%
at 24 hours post radiation. Percentage of cell viability was determined utilizing
the same Trypan blue exclusion assay, where the number of viable cells was
normalized to the total number of viable and dead cells. In Figure 3.1.1f, the
percentage of viable cells were almost 97%, indicating minimum cell death
occurred within 24 hours post treatment.
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To further confirm the increase in growth inhibition after Beclin-1 silencing, I
performed clonogenic survival assay to measure the ability of colony formation in
MCF-7 after Beclin-1 silencing. A clonogenic survival assay is often used to
measure the efficacy of a treatment by observing the ability of a single cell to
form a colony. In Figure 3.1.1g, radiation alone could inhibit about 30% the ability
of colony formation. However, when radiation was combined with Beclin-1
silencing, the inhibition effect was increased to about 50%. Thus, silencing of
Beclin-1 could inhibit autophagy and significantly suppress the colony formation
in the radiated MCF-7 cells. The data suggested that radiation-induced
autophagy in MCF-7 performed cytoprotective function.
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a.

b.

Figure 3.1.1 Silencing of Beclin-1 inhibited radiation-induced autophagy in MCF7 cell. (a) Western blot analyses of endogenous Beclin-1 in MCF-7 cells infected
with control or Beclin-1 shRNA. β-actin was used as a loading control. (b)
Acridine orange images were taken at 24 hours post radiation using an inverted
fluorescent microscope. NT: no treatment. IR: radiation.
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c.

d.

Figure 3.1.1 Silencing of Beclin-1 inhibited radiation-induced autophagy in MCF7 cell. (c) Acridine orange staining of acidic vesicles quantified by flow cytometry.
Measurement of autophagy induction based on % acidic vesicle formation was
monitored by acridine orange staining and quantified by flow cytometry within 0
hour and 24 hours post radiation. *, p < 0.05; **, p < 0.01; ***, p < 0.001. Oneway ANOVA was followed by Bonferroni post-hoc test. Results were taken from
three independent experiments. (d) Cell lysates were collected at NT, 0 hour, and
24 hours post radiation and subjected to Western blot analyses with the indicated
antibodies. β-actin was used as a loading control. NT: no treatment. IR: radiation.
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e.

f.

g.
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Figure 3.1.1 Silencing of Beclin-1 inhibited radiation-induced autophagy in MCF7 cell. (e) MCF-7 cells were plated with a concentration of 5x104 cells per well
(six well tissue culture dish). The cells were exposed to radiation (5x2 Gy) over a
period of 3 days. Number of viable cells was determined by Trypan Blue
exclusion assays at NT, 0 hour and 24 hours post radiation. (f) Percentage of cell
viability was determined by Trypan blue exclusion assay. The viable cell number
was normalized to the total number of viable cells and dead cells. (g) After
exposure to radiation, the cells were immediately plated with a concentration of
1x104 cells per well (six well tissue culture dish). Number of colonies was
determined by clonogenic survival assays over a period of 12 days. *, p < 0.05;
**, p < 0.01; ***, p < 0.001. One-way ANOVA was followed by Bonferroni posthoc

test.

Results

were

taken

from

three

independent

experiments.
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3.1.2 The interaction between Beclin-1 and the anti-apoptotic Bcl-2 proteins
in MCF-7 cells
In order to enhance the level of radiation-induced autophagy in MCF-7 cell, I
generated a MCF-7/shBcl-2 cell and examine the interaction between Bcl-2
family proteins and Beclin-1. In Figure 3.1.2a, silencing of Bcl-2 in MCF-7 was
demonstrated by Western blot analyses. The levels of Bcl-xL, Mcl-1 and Beclin-1
remained unchanged after Bcl-2 was silenced as compared to the control cells.
Next, co-immunoprecipitation assay was performed to determine the ability of
Bcl-2 family proteins to interact with Beclin-1. In Figure 3.1.2b, the interaction of
Beclin-1 to Bcl-xL or Mcl-1 was very weak or undetectable, respectively.
However, endogenous Bcl-2 in MCF-7 clearly bound to Beclin-1, indicating that
interfering with Bcl-2/Beclin-1 interaction could alter the level of radiation-induced
autophagy in MCF-7 cell.
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a.

b.

Figure 3.1.2 Endogenous Bcl-2 interacts with Beclin-1 in MCF-7 cells. (a)
Western blots analyses for the silencing of Bcl-2. MCF-7 cells were infected with
lentivirus-encoding shRNA for non-targeting control or Bcl-2. GAPDH was used
as a loading control (b) Immunoprecipitation (IP) with Beclin-1. Total cell lysates
were subjected to IP with anti-Beclin-1. Western blot analyses were carried out
on the precipitated samples with the indicated antibodies.
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3.1.3 Silencing of Bcl-2 enhanced the level of radiation-induced autophagy
in MCF-7 cell.
To examine whether silencing of Bcl-2 could interfere with the level of autophagy
induced by radiation in MCF-7 cell, I assessed the formation of acidic vesicular
organelles by acridine orange and quantified by flow cytometry.
Figure 3.1.3a demonstrates the Bcl-2 level after the introduction of Bcl-2 shRNA
into MCF-7 cell. In Figure 3.2.3b, acridine orange images indicate that radiation
alone induced autophagic vesicle formation in MCF-7 cell. Silencing of Bcl-2
further increased the formation of the autophagic vesicles caused by radiation. In
Figure 3.1.3c, quantification of acidic vesicular organelles indicate that in MCF-7
cell the percentage of acidic vesicles came from 3.7% in no treatment condition
to 10.5% at 0 hour and 18.8% at 24 hours post radiation. On the other hand, in
MCF-7/shBcl-2 the percentage of acidic vesicles from 6.6% in no treatment
condition was brought up to 21.6% at 0 hour and to 26.2% at 24 hours by
radiation.
In addition to the acridine orange results indicating the enhancement of
autophagy by Bcl-2 silencing, Western blot analyses in Figure 3.1.3d show that
LC3-II accumulation was much higher in MCF-7/shBcl-2 cell as compared to
MCF-7 cell, indicating higher level of autophagic vesicle formation. Furthermore,
p62 degradation was observed earlier in MCF-7/shBcl-2 cell (started at 6 hour
post radiation) as compared to MCF-7 cell (started at 24 hour post radiation).
In short, the data in Figure 3.1.3 suggest that silencing of Bcl-2 could enhance
the level of radiation-induced autophagy in MCF-7 cell.
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a.

b.

Figure 3.1.3 Silencing of Bcl-2 enhanced the level of radiation-induced
autophagy in MCF-7 cell. (a) Bcl-2 level was analyzed using Western blotting in
the control and Bcl-2 shRNAs transfected vectors. (b) Acridine orange images
were taken 24 hours post radiation using an inverted fluorescent microscope.
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c.

d.

Figure 3.1.3 Silencing of Bcl-2 enhanced the level of radiation-induced
autophagy in MCF-7 cell. (c) Measurement of autophagy induction based on %
acidic vesicle formation was monitored by acridine orange staining and quantified
by flow cytometry within 0 hour and 24 hours post radiation. *, p < 0.05; **, p <
0.01; ***, p < 0.001. One-way ANOVA was followed by Bonferroni post-hoc test.
Results were taken from three independent experiments. (d) MCF-7 cells were
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exposed to radiation (5x2 Gy) over a period of 3 days. Cell lysates were collected
at 0, 6, 12, and 24 hours post radiation and subjected to Western blot analyses
with the indicated antibodies. β-actin was used as a loading control.
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3.1.4 Enhancement of autophagy by Bcl-2 silencing increased growth
inhibition effects produced by radiation in MCF-7 cell.
Trypan blue exclusion assays were performed to determine the number of viable
cells after exposure to radiation. In Figure 3.1.4a, radiation alone could
significantly inhibit cell growth in MCF-7/control cell at 0 hour and 24 hours post
radiation. The growth inhibition effects of radiation were further increased in
MCF-7/shBcl-2, in contrast with the hypothesis that enhancement of autophagy
would further protect the cells from radiation. In Figure 3.1.4b, percentage cell
viability was determined by normalizing the number of viable cells to the total
number of viable cells and dead cells after 0 hour and 24 hours post radiation,
indicating that minimum cell death was observed. Furthermore, Western blot
analysis suggests that no cleaved-PARP expression was observed in either
MCF-7/control or MCF-7/shBcl-2 cells, indicating minimum apoptosis happened
within 24 hours post radiation (Figure 3.1.4c). In addition, data in Figure 3.1.4d
taken from clonogenic survival assay indicates that radiation in combination with
Bcl-2 silencing could significantly increase the inhibition effects on colony
formation in MCF-7 cells as compared to radiation alone. In short, data in Figure
3.1.4 suggests that enhancement of autophagy through Bcl-2 silencing increased
the growth inhibition effects produced by radiation.
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a.

b.

Figure 3.1.4 Enhancement of autophagy through Bcl-2 silencing increased the
growth inhibition effects produced by radiation. MCF-7 cells were exposed to
radiation (5x2 Gy) over a period of 3 days. (a) Number of viable cells was
determined by Trypan blue exclusion assays in NT cells, and at 0 hour and 24
hours post radiation. (b) Number of viable cells was normalized to the total
number of viable and dead cells to calculate for the percentage of viable cells.
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c.

d.
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Figure 3.1.4 Enhancement of autophagy through Bcl-2 silencing increased the
growth inhibition effects produced by radiation. (c) Cell lysates were collected
and Western blot analyses were performed with the indicated antibodies. (d)
Number of colonies was determined by clonogenic survival assays over a period
of 12 days. *, p < 0.05; **, p < 0.01; ***, p < 0.001. One-way ANOVA was
followed by Bonferroni post-hoc test. Results were taken from three independent
experiments.
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Section 2: Radiation induced non-protective autophagy in Hs578t cell.
3.2.1 Silencing of Beclin-1 inhibited radiation-induced autophagy and
minimum changes in radiation sensitivity were observed.
Recent studies from our lab have proposed that 5x2 Gy radiation could induce
non-protective autophagy in Hs578t cells. Pharmacological interference of
autophagy using 3-methyladenine (10 mM) and chloroquine (25 uM) did not
result in growth inhibition or cell death. To confirm these previous data,
Hs578t/shBeclin-1 cells were generated. Figure 3.2.1a shows that Beclin-1
expression was suppressed in Hs578t. Cells were stained with acridine orange
and subsequent quantification of acidic vesicular organelles was followed. In
Figure 3.2.1b acridine orange images indicate that radiation alone strongly
induced autophagic vesicle formation in Hs578t cell. The level of acridine orange
staining was significantly attenuated after Beclin-1 was silenced. Figure 3.2.1c
indicates that radiation alone could bring the autophagic vesicle level from 8.1%
in NT condition to 40.4% at 0 hour post radiation. Silencing of Beclin-1
expression could suppress about 25% of the autophagic vesicle level, indicating
that autophagy induction was successfully inhibited. To examine whether Beclin1 silencing could inhibit autophagic flux, I performed Western blot to analyze p62
degradation. In Figure 3.2.1d, degradation of p62 started as early as 0 hour post
radiation and continued to be clearly degraded at 24 hours post radiation in
Hs578t cells. On the other hand, p62 level remained unchanged in
Hs578t/shBeclin-1 cells. Thus, silencing of Beclin-1 could inhibit autophagy
induction and completion in Hs578t cells.
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Next, in order to determine the growth ability of the cells after interference with
autophagy through Beclin-1 silencing, I performed Trypan blue exclusion assay,
counting for the number of viable cells. Figure 3.2.1e indicates that no significant
differences in growth inhibition effects between radiation alone and radiation in
combination with Beclin-1 silencing were detected. Percentage of cell viability
calculated in Figure 3.2.1f suggests that minimum cell death happened within 24
hours post radiation. Furthermore, clonogenic survival assay indicates that
radiation alone could suppress about 20% of colony formation in Hs578t.
Moreover, inhibition of autophagy by silencing of Beclin-1 did not alter the colony
formation in the presence of radiation (Figure 3.2.1g), in agreement with our
previous data (manuscript in preparation). In other words, inhibition of autophagy
through Beclin-1 silencing did not change the sensitivity of Hs578t cells to
radiation.
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a.

b.

Figure 3.2.1 Silencing of Beclin-1 inhibited radiation-induced autophagy in
Hs578t cell. (a) Western blot analyses of endogenous Beclin-1 in Hs578t cells
transfected with control or Beclin-1 shRNAs lentivirus constructs. α–tubulin was
used as a loading control. (b) Acridine orange images were taken at 24 hours
post radiation using an inverted fluorescent microscope.
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d.
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Figure 3.2.1 Silencing of Beclin-1 inhibited radiation-induced autophagy in
Hs578t cell. (c) Acridine orange staining of acidic vesicles quantified by flow
cytometry. Measurement of autophagy induction based on % acidic vesicle
formation was monitored by acridine orange staining and quantified by flow
cytometry within 0 hour and 24 hours post radiation. *, p < 0.05; **, p < 0.01; ***,
p < 0.001. One-way ANOVA was followed by Bonferroni post-hoc test. Results
were taken from three independent experiments. (d) Cell lysates were collected
in NT cells, and 0 hour and 24 hours post radiation. The lysates were subjected
to Western blot analyses with the indicated antibodies. β-actin was used as a
loading

control.
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f.

g.
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Figure 3.2.1 Silencing of Beclin-1 inhibited radiation-induced autophagy in
Hs578t cell. (e) Hs578t cells were plated with a concentration of 5x104 cells per
well (six well tissue culture dish). The cells were exposed to radiation (5x2 Gy)
over a period of 3 days. Number of viable cells was determined by Trypan Blue
exclusion assays in NT cells, and 0 hour and 24 hours post radiation. (f)
Percentage of cell viability was determined by Trypan blue exclusion assay. The
viable cell number was normalized to the total number of viable cells and dead
cells. (g) After exposure to radiation, the cells were immediately plated with a
concentration of 1x104 cells per well (six well tissue culture dish). Number of
colonies was determined by clonogenic survival assays over a period of 12 days.
*, p < 0.05; **, p < 0.01; ***, p < 0.001. One-way ANOVA was followed by
Bonferroni post-hoc test. Results were taken from three independent
experiments.
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3.2.2 The expression levels of autophagy-related proteins in MCF-7 and
Hs578t cells
To identify factors that could be responsible for the induction of different types of
autophagy, I determined the expression levels of autophagy related proteins in
MCF-7 and Hs578t cells. Western blot analyses in Figure 3.2.2 indicates that
Atg-5, a critical regulator of autophagy, was similarly expressed in the two cell
lines. On the other hand, the expression of Beclin-1, an essential initiator of
autophagy, was much higher in Hs578t as compared to MCF-7 cells. Since
Beclin-1 has been shown to interact with the anti-apoptotic Bcl-2 proteins, and
the interaction inhibits Beclin-1 autophagic function (Liang et al., 1998), it is
important to determine the expression levels of the anti-apoptotic Bcl-2 proteins.
The Western blot indicates that Bcl-xL and Mcl-1 were similarly expressed in
MCF-7 and Hs578t cells. Surprisingly, while MCF-7 expressed high level of Bcl2, Bcl-2 expression was undetectable in Hs578t.
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Figure 3.2.2 Western blot analyses demonstrated the expression levels of
autophagy-related proteins in MCF-7 and Hs578t cells. Equal amounts of protein
lysates were subjected to Western blot analyses using the indicated antibodies.
"
"
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3.2.3 The interaction between Beclin-1 and the exogenous Bcl-2 in Hs578t
cell.
In Figure 3.2.3a, Bcl-2 retrovirus construct was introduced into Hs5787t cells and
the expression was demonstrated by Western blot analyses. The levels of Bcl-xL,
Mcl-1 and Beclin-1 remained unchanged after Bcl-2 introduction as compared to
the control cells. To examine the interaction between Beclin-1 and Bcl-2 proteins
in Hs578t cells, I performed co-immunoprecipitation as demonstrated in Figure
3.2.3b. The interaction of Beclin-1 to Bcl-xL or Mcl-1 was very weak or nondetectable, respectively. However, the interaction between Beclin-1 and
exogenous Bcl-2 was clearly observed.
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a.

b.

Figure 3.2.3 The interaction between Beclin-1 and the exogenous Bcl-2 in
Hs578t cell. (a) Western blot analyses for the introduction of Bcl-2. Hs578t cells
were infected with retrovirus-encoding RNA constructs for non-targeting control
or Bcl-2 expressing vector. (b) Co-immunoprecipitation (IP) with Beclin-1. Total
cell lysates were subjected to IP with anti-Beclin-1. Western blot analyses were
carried out on the precipitated samples with the indicated antibodies.

"

42"
"
3.2.4 Introduction of Bcl-2 inhibited radiation-induced autophagy in Hs578t
cell.
To examine whether the introduction of Bcl-2 contributed to the induction of
autophagy in Hs578t cells, I determined the differences in autophagy level in
Hs578t/control and Hs578t/Bcl-2 using acridine orange staining.
Figure 3.2.3a demonstrates the level of Bcl-2 in Hs578t/control and Hs578t/Bcl-2
cells. In Figure 3.2.3b acridine images indicate that radiation induced significant
level of autophagic vesicles in Hs578t/control and lower level of the vesicles was
detected in Hs578t/Bcl-2. Quantification of the acidic vesicles shown in Figure
3.2.3c indicates that the percentage of acidic vesicles in Hs578t/control
increased from 8.1% in NT condition to 40.4% at 0 hour post radiation. At 24
hour, the amount of acidic vesicular organelles went down to 11.1%, suggesting
that the vesicles were degraded and autophagy went to completion. In
Hs578t/Bcl-2 cells, the percentage of acidic vesicular organelles started at 12.5%
in NT conditions. The amount went up to 32.7% within 0 hour post radiation.
However, at 24 hours post radiation, the amount of acidic vesicular organelles
was 22.5%, indicating that degradation of acidic vesicular organelles in
Hs578t/Bcl-2 was attenuated as compared to that in Hs578t/control cell. In
addition, Western blot analyses in Figure 3.2.3d indicate that in Hs578t/control
cell radiation could induce LC3-II accumulation as early as 0 hour post radiation.
The level of LC3-II accumulation gradually went down together with the downregulation of p62 protein, suggesting that autophagy was induced and went to
completion within 24 hours post radiation. On the other hand, in Hs578t/Bcl-2 cell
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radiation could promote the accumulation of LC3-II. However, down-regulation of
LC3-II and p62 were not observed within 24 hours post radiation. The data in
Figure 3.2.3 suggest that introduction of Bcl-2 into Hs578t cell could attenuate
the formation of autophagic vesicles and inhibited the degradation step of
autophagy induced by radiation.
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a.

b.

Figure 3.2.4 Introduction of Bcl-2 inhibited radiation-induced autophagy in
Hs578t cell. Hs578t cells were exposed to radiation (5x2 Gy) over a period of 3
days. (a) Bcl-2 level was analyzed by Western blot analyses comparing the
control with Bcl-2 transfected vectors. (b) Acridine orange images were taken at
24 hours post radiation using an inverted fluorescent microscope.

"

45"
"
c.

d.
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Figure 3.2.4 Introduction of Bcl-2 inhibited radiation-induced autophagy in
Hs578t cell. Hs578t cells were exposed to radiation (5x2 Gy) over a period of 3
days. (c) Acridine orange staining of acidic vesicles quantified by flow cytometry.
Measurement of autophagy induction based on % acidic vesicular organelles
was monitored by acridine orange staining and quantified by flow cytometry in NT
cells and at 0 hour and 24 hours post radiation. *, p < 0.05; **, p < 0.01; ***, p <
0.001. One-way ANOVA was followed by Bonferroni post-hoc test. Results were
taken from three independent experiments. (d) Cell lysates were collected in NT
cells, and at 0,6,12 and 24 hours post radiation. The lysates were subjected to
Western blot analyses with the indicated antibodies.
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3.2.5 Inhibition of autophagy by exogenous expression of Bcl-2 produced
minimum changes in growth inhibition effects produced by radiation in
Hs578t cell.
Trypan blue exclusion assays were performed to determine the number of viable
cells after exposure to radiation. In Figure 3.2.4a, radiation alone could mildly
inhibit cell growth in Hs578t/control cell at 0 hour and 24 hours post radiation.
Furthermore, stable expression of Bcl-2 in Hs578t did not alter the sensitivity of
the cells to radiation. In Figure 3.2.4b, percentage cell viability was determined
by normalizing the number of viable cells to the total number of viable cells and
dead cells after 0 hour and 24 hours post radiation, indicating that minimum cell
death was observed. Furthermore, Western blot analyses suggest that no
cleaved-PARP expression was observed in either Hs578t/control or Hs578t/Bcl-2
cells, indicating minimum apoptosis happened within 24 hours post radiation
(Figure 3.2.4c). In addition, data in Figure 3.2.4d taken from clonogenic survival
assay indicates that radiation in combination with Bcl-2 stable expression did not
change the sensitivity of Hs578t to the growth inhibition effects on colony
formation after exposure to radiation. In short, data in Figure 3.2.4 suggests that
inhibition of autophagy through Bcl-2 stable expression did not alter the
sensitivity of Hs578t to radiation.
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a.

b.

Figure 3.2.5 Inhibition of autophagy by exogenous expression of Bcl-2 produced
minimum changes in growth inhibition effects produced by radiation in Hs578t
cell. Hs578t cells were plated with a concentration of 5x104 cells per well (six well
tissue culture dish). The cells were exposed to radiation (5x2 Gy) over a period of
3 days. (a) Number of viable cells was determined by Trypan Blue exclusion
assays in NT cells, and 0 hour and 24 hours post radiation. (b) Percentage of cell
viability was determined by Trypan blue exclusion assay. The viable cell number
was normalized to the total number of viable cells and dead cells.
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d.

Figure 3.2.5 Inhibition of autophagy by exogenous expression of Bcl-2 produced
minimum changes in growth inhibition effects produced by radiation in Hs578t
cell. (c) Cell lysates were collected and Western blot analyses were performed
with the indicated antibodies. (d) After exposure to radiation, the cells were
immediately plated with a concentration of 1x104 cells per well (six well tissue
culture dish). Number of colonies was determined by clonogenic survival assays
over a period of 12 days. *, p < 0.05; **, p < 0.01; ***, p < 0.001. One-way
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ANOVA was followed by Bonferroni post-hoc test. Results were taken from three
independent experiments.
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Section 4: Discussion
Most breast tumor cells undergo autophagy after exposure to radiation
(Rodemann et al., 2011). Autophagy is an important catabolic process which
removes damaged proteins and organelles to maintain cellular homeostasis
(Mizushima and Komatsu, 2011). Even though pro-survival autophagy is the
main function of autophagy in response to stresses (He and Klionsky, 2009;
Ouyyang et al., 2012), it has been suggested that autophagy can perform
different functions in tumor cells.
Data from this study and previous studies suggested that radiation at 5x2 Gy
induced cytoprotective autophagy in MCF-7 cells. Inhibition of autophagy by
silencing of Beclin-1 led to an increase in growth inhibition produced by radiation
in MCF-7 cells (Figure 3.1.1). Interestingly, enhancement of autophagy by
silencing of Bcl-2 did not protect the cells from radiation growth inhibition effects.
On the other hand, enhancement of autophagy by silencing of Bcl-2 sensitized
MCF-7 cells to radiation (Figure 3.1.4). It was shown that cell death was not the
mode of sensitization to radiation either in Beclin-1 silencing or Bcl-2 silencing
MCF-7 cells. Thus further experiments were needed to determine the mode of
sensitization to radiation growth inhibition effects.
Data from this work and previous works from the lab suggested that radiationinduced autophagy in Hs578t played non-protective function. Inhibition of
autophagy by silencing of Beclin-1 could not sensitize the cells to radiation
(Figure 3.2.1). Furthermore, Hs578t is a Bcl-2 non-expressing cell line (Figure
3.2.2). Stable expression of Bcl-2 resulted in Beclin-1/Bcl-2 interaction, which led
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to inhibition of autophagy induced by radiation. Similarly, inhibition of autophagy
by Bcl-2 stable expression did not alter the sensitivity of Hs578t cells to radiation
(Figure 3.2.4).
In conclusion, data from current study suggested that interference with
cytoprotective autophagy (in MCF-7 cell) could result in an increase in sensitivity
to treatment (radiation). However, alterations in non-protective autophagy (in
Hs578t cell) did not result in either increased or decreased radiation sensitivity.
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Section 5: Future Studies
In MCF-7 cells, further studies are needed to determine modes of increased
radiation sensitivity after Beclin-1 and Bcl-2 silencing. Since it was shown that
cell death was not the mode of sensitization, it could be senescence growth
arrest playing the role in the increase of growth inhibition after exposure to
radiation. On the other hand, recent studies from our lab demonstrated that
cytoprotective autophagy could be converted into cytostatic autophagy in the
same cellular system. Cytostatic autophagy leads to cellular growth arrest.
Therefore, it is possible that silencing of Bcl-2 in MCF-7 cell led to a conversion
from cytoprotective into cytostatic autophagy. Therefore, future studies could be
involved in manipulating the level of autophagy induced in Bcl-2 silencing cells.
Also, it is important to assess whether enhancement of autophagy by different
approach such as through rapamycin treatment could lead to similar sensitivity
as observed in Bcl-2 silencing cells.
In Hs578t, it looks like manipulating non-protective autophagy does not result in
any change in radiation sensitivity. However, it is interesting that exogenous Bcl2 did not inhibit autophagy at the autophagic vesicle formation level. It is possible
that Bcl-2 regulates other autophagy-related proteins downstream of Beclin-1.
Future studies could be done to understand whether Bcl-2 is interacting or
regulating autophagy-related proteins other than Beclin-1.
It is also important to assess the sensitivity to treatment in other cell lines that
induce cytoprotective autophagy and non-protective autophagy.
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